Cargando…
Extracellular matrix differences in glioblastoma patients with different prognoses
Glioblastoma is the most common malignant central nervous system tumor. Patient outcome remains poor despite the development of therapy and increased understanding of the disease in the past decades. Glioma cells invade the peritumoral brain, which results in inevitable tumor recurrence. Previous st...
Autores principales: | Virga, József, Szivos, László, Hortobágyi, Tibor, Chalsaraei, Mahan Kouhsari, Zahuczky, Gábor, Steiner, László, Tóth, Judit, Reményi-Puskár, Judit, Bognár, László, Klekner, Almos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313004/ https://www.ncbi.nlm.nih.gov/pubmed/30655832 http://dx.doi.org/10.3892/ol.2018.9649 |
Ejemplares similares
-
Epigenetics of Meningiomas
por: Murnyák, Balázs, et al.
Publicado: (2015) -
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
por: Murnyák, Balázs, et al.
Publicado: (2017) -
Meningioma recurrence
por: Hortobágyi, Tibor, et al.
Publicado: (2016) -
Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity
por: Hutóczki, Gábor, et al.
Publicado: (2021) -
Pathophysiology of Meningioma Growth in Pregnancy
por: Hortobágyi, Tibor, et al.
Publicado: (2017)